High ENT1 and DCK gene expression levels are a potential biomarker to predict favorable response to nelarabine therapy in T-cell acute lymphoblastic leukemia.

Koshi AkahaneYasushi MurakamiKeiko KagamiMasako AbeDaisuke HaramaTamao ShinoharaAtsushi WatanabeKumiko GoiRie NishiTakahiro YamauchiShunsuke KimuraJunko TakitaA Thomas LookMasayoshi MinegishiKanji SugitaTakeshi Inukai

Published in: Hematological oncology (2019)

Keyphrases

acute lymphoblastic leukemia
gene expression
dna methylation
allogeneic hematopoietic stem cell transplantation
replacement therapy
smoking cessation